You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

459 Results
Document
Dec 1969
Document
Jul 2024
Document
Jul 2024
Document
Jul 2024
This hub contains tools and resources for primary care providers, colposcopists and other health care providers. This material supports the Ontario...
Document
Dec 1969
Print This patient guide will help you understand: What is anxiety? What can cause anxiety when you have cancer? How is anxiety treated? What...
In October 2024, the Ontario Breast Screening Program lowered the starting age for screening from age 50 to age 40.This page provides breast cancer...
Print This information is meant to help healthcare providers prepare for conversations with their patients ages 40 to 49 about whether breast...
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
ODB - General Benefit
    dexamethasone
New Drug Funding Program
    Calaspargase Pegol (Outpatient) - Newly Diagnosed Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed_Biphenotypic Leukemia
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
cyclophosphamide,
DOXOrubicin,
vinCRIStine,
dexamethasone,
calaspargase pegol
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2024
Document
Nov 2024

Pages